Physician profile
Jennifer Hook
NPI 1033662044
$13,090.26
in general payments reported to CMS, 2019-2025
49 companies · $3,953 in 2025
The $3,953 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,143 · 2022: $2,139 · 2023: $1,348 · 2024: $3,508 · 2025: $3,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,633 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,633.12 |
| Education | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,046.55 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,009.05 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $845.18 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $827.92 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $699.31 | 2021-2025 | |
| Novo Nordisk INC | $644.30 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $501.03 | 2021-2025 | Reyvow, Emgality, Mounjaro |
| Eisai INC. | $383.73 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $381.88 | 2024-2025 | Rexulti |
| Amgen INC. | $370.92 | 2021-2025 | Evenity, Prolia |
| Lundbeck LLC | $359.71 | 2024-2025 | Vyepti, Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $320.15 | 2024-2025 | Caplyta |
| Idorsia Pharmaceuticals US INC | $306.83 | 2022-2023 | Quviviq |
| Astellas Pharma US INC | $299.99 | 2023-2024 | Veozah |
| Glaxosmithkline, LLC. | $285.88 | 2021-2025 | Trelegy Ellipta |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $284.00 | 2021-2025 | |
| Axsome Therapeutics, INC. | $255.96 | 2024-2025 | Symbravo, Auvelity, Sunosi |
| Exact Sciences Corporation | $200.31 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $151.43 | 2021 | |
| Esperion Therapeutics, INC. | $144.09 | 2021 | |
| Corcept Therapeutics | $143.32 | 2024 | Korlym |
| Alkermes, INC. | $141.81 | 2024-2025 | Aristada, Vivitrol, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $139.67 | 2024-2025 | Austedo Xr, Austedo Xr |
| Biohaven Pharmaceutical Holding Company LTD. | $134.66 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $126.88 | 2021-2025 | Trintellix, Cuvitru |
| Harmony Biosciences LLC | $122.98 | 2024 | |
| Aimmune Therapeutics, INC. | $115.33 | 2024-2025 | Zenpep |
| Abbott Laboratories | $102.86 | 2022-2024 | Freestyle Libre 3 |
| Impel Pharmaceuticals INC. | $91.06 | 2023 | Trudhesa |
| Neurocrine Biosciences, INC. | $87.64 | 2024-2025 | Ingrezza |
| Ablative Solutions, INC. | $76.74 | 2022 | |
| Xeris Pharmaceuticals, INC. | $62.10 | 2023 | Gvoke Hypopen |
| Ascensia Diabetes Care US INC. | $61.16 | 2025 | |
| Baxter Healthcare | $44.92 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Collegium Pharmaceutical, INC. | $40.90 | 2025 | Jornay Pm |
| Amarin Pharma, INC. | $39.65 | 2021 | |
| Almatica Pharma LLC | $32.54 | 2024-2025 | Loreev Xr |
| Grifols USA, LLC | $25.68 | 2025 | Prolastin-C Liquid |
| Dexcom, INC. | $21.73 | 2023 | Dexcom G6 Transmitter |
| Verona Pharma, INC. | $21.41 | 2025 | Ohtuvayre |
| Vanda Pharmaceuticals INC. | $18.58 | 2025 | Fanapt |
| Vertex Pharmaceuticals Incorporated | $18.16 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $17.36 | 2025 | Uptravi, Opsumit |
| Antares Pharma, INC. | $16.22 | 2024 | Xyosted |
| Kowa Pharmaceuticals America, INC. | $15.94 | 2025 | Zoryve |
| Radius Health, INC. | $15.87 | 2025 | Tymlos |
| Upsher-Smith Laboratories LLC | $13.43 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.38 | 2022 | |
| Nestle Healthcare Nutrition INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.